Home
Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. Market Share Analysis for May 2026

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD.

Health > Biotechnology and Pharmaceuticals

Domainamicusrx.com

Year Founded2002

Employees201 - 500

Annual Revenue$200M - $500M

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. (including company regionals)

amicusrx.com

See more website traffic and engagement information

Amicus Therapeutics, Inc. Revenue up to May 2026 is 200M - 500M

revenue generated by Amicus Therapeutics, Inc. top domains

Amicus Therapeutics, Inc. top domains revenue over 3 years

Revenue for Amicus Therapeutics, Inc. top domains

amicusrx.com200M - 500M

See more with Sales Intelligence

Amicus Therapeutics, Inc. Stock price in May 2026

Amicus Therapeutics, Inc. stock is traded under the ticker #FOLD. Below you can review Amicus Therapeutics, Inc. stock performance in the past 12 months up to May 2026

Total visits to Amicus Therapeutics, Inc.'s top domains

Understand Amicus Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

amicusrx.com17.3K

See more with Sales Intelligence

Avg. visit duration in Amicus Therapeutics, Inc.'s top domains

Analyze Amicus Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

amicusrx.com00:00:24

See more with Sales Intelligence

Avg. pageviews on Amicus Therapeutics, Inc.'s top domains

See how Amicus Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

amicusrx.com1.72

See more with Sales Intelligence

Amicus Therapeutics, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

biomarin.comCompany NameBioMarinEmployees1001 - 5000HQUnited States, California, San RafaelAnnual revenue> $1BTotal visits109.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Amicus Therapeutics, Inc.

These are the website technologies, by industry, used by Amicus Therapeutics, Inc. top domains

Advertising (8)

DoubleClick

Conversion & Analytics (4)

Google Analytics

Social (4)

Instagram

Widget (4)

Twemoji

More Technologies

11

See all

News & Signals from Amicus Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGenomenon Inc. partnered with Amicus Therapeutics, Inc. on Mar 10th '26.Genomenon today announced a strategic sponsorship from Amicus Therapeutics to accelerate awareness, diagnosis, and research for Fabry disease.

NewsBioMarin Pharmaceutical Inc. integrates with Amicus Therapeutics, Inc..The deal, approved by both boards, expands BioMarin's rare disease portfolio with Amicus' therapies for Fabry and Pompe diseases and adds high-growth revenue streams.

NewsAmicus Therapeutics, Inc. attended event 43rd Annual J.P. Morgan Healthcare Conference on May 7th '25.PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) - Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2025 Health Care Conference in Las Vegas, NV on Wednesday, May 14, 2025, at 8:00 a.m. P.T.